PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsHyperglycemia
MeSH D006943 - hyperglycemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D044882:Glucose metabolism disorders
1 Company
2 Drugs
$
Success rate
D006943: 
Hyperglycemia
10 Companies
7 Drugs
$
Success rate
D018149:Glucose intolerance
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
BioconInsulin glargine Semglee  2021-07-28   
MylanInsulin glargine Semglee  2020-06-11   
SanofiInsulin lispro Admelog  2017-12-11   
Insulin lispro Insulin lispro Sanofi  2017-07-19   
Insulin glargine Lantus  2000-04-20   
Lixisenatide, Insulin glargine Soliqua  2016-11-21   
Lixisenatide, Insulin glargine Suliqua  2017-01-11   
Insulin glargine Toujeo  2015-02-25   
Insulin glargine Toujeo (previously Optisulin)  2000-06-26   
Merck & CoInsulin glargine Lusduna  2017-01-03   
Eli LillyInsulin glargine Abasaglar (previously Abasria)  2014-09-09   
Insulin glargine Basaglar  2015-12-16 $685.2 M Q4/23-Q3/24 
Insulin lispro Humalog  1996-06-14 $2,071.6 M Q4/23-Q3/24 
Insulin lispro Humalog Mix  1999-12-22   
Insulin lispro Liprolog  1997-05-07   
Insulin lispro Lyumjev  2020-06-15   
Insulin lispro Lyumjev (previously Liumjev)  2020-03-24   
Insulin glargine Rezvoglar  2021-12-17   
ViatrisInsulin glargine Semglee  2018-03-23   
Novo NordiskInsulin aspart, Insulin degludec Ryzodeg  2015-09-25   
Insulin degludec Tresiba  2015-09-25   
Liraglutide, Insulin degludec Xultophy  2016-11-21   
Clinical Trials
Historical Success Rate
Phase 1
64%
9/14
Phase 2
70%
7/10
Phase 3
56%
14/25
Approved: 4Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Biocon
Insulin glargine
Mylan
Insulin glargine
Sanofi
Insulin lispro,
Lixisenatide,
Insulin glargine,
Enoblituzumab,
Aspartame,
Corticoids,
Insulatard,
Mms,
Viaject,
Lyspro,
Articular,
Arm1,
Bolus,
Ssri
Merck & Co
Insulin glargine,
Losartan,
Angiotensin ii,
Avexitide,
Sodium chloride,
Sodium lactate,
Microcrystalline cellulose,
Viaject,
Lyspro,
Solumedrol,
Exendin9,
Kcl
Eli Lilly
Insulin lispro,
Insulin glargine,
Albumin,
Ademetionine,
Sodium chloride,
Aspartame,
Insulatard,
Viaject,
Lyspro,
Sglt2,
Bolus,
Ssri,
Kcl
Novo Nordisk
Insulin aspart,
Liraglutide,
Insulin degludec,
Viaject,
Gluconorm,
Bolus
Corcept Therapeutics
Mifepristone
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use